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To the editor
I read with great interest the paper by Jin et al in a recent issue of your journal.1 
The article is highly thought-provoking. Interestingly, the past few years have also 
seen the emergence of nitric oxide synthetase inhibitors, especially 7-nitroinda-
zole, as novel new agents with significant benefits in opioid pain management and 
withdrawal.
For instance, 7-nitroindazole attenuates the development of tolerance to the anti-
nociceptive activity of kappa and mu opioid receptors.2 Similarly, 7-nitroindazole 
blocks the neurotoxicity secondary to ketamine in animal models.3 This may very well 
play a significant role in protecting the human brain from the toxicity of ketamine, 
especially in the pediatric population.
7-Nitroindazole also has a negative impact on morphine dependency.4 Tian 
et al have shown that 7-nitroindazole decreases physical dependence on opioid 
agonist/antagonist agents such as butorphanol.5 Medvedev et al have recently 
shown that administration of 7-nitroindazole also decreases symptoms of opioid 
withdrawal, such as tremors and diarrhea.6 The clinical benefit of 7-nitroindazole 
in individuals with opioid withdrawal is that it does not cause hypertension, 
unlike other nitric oxide synthase inhibitors, such as L-NG-nitroarginine methyl   
esters.7
7-Nitroindazole may also have other benefits. For instance, 7-nitroindazole injection 
into the bronchial vasculature decreases pulmonary changes such as edema secondary 
to hypoxic trauma.8 The examples cited here clearly illustrate the beneficial effects 
of 7-nitroindazole and the need for further large-scale studies to elaborate fully its 
beneficial effects in pain management.
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